Tang Capital Management as of Dec. 31, 2013
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 13 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pdl Biopharma Inc cnv | 27.1 | $39M | 26M | 1.49 | |
| Salix Pharmaceuticals | 18.9 | $27M | 300k | 89.94 | |
| OPK CB 3 01FEB2033 144A BOND 01feb2033 | 11.9 | $17M | 14M | 1.22 | |
| Mirati Therapeutics | 10.9 | $16M | 939k | 16.63 | |
| BioMarin Pharmaceutical (BMRN) | 9.0 | $13M | 182k | 70.35 | |
| Intermune Inc note 2.500% 9/1 | 7.4 | $11M | 12M | 0.88 | |
| OncoGenex Pharmaceuticals | 6.0 | $8.6M | 1.0M | 8.34 | |
| MannKind Corporation | 3.9 | $5.6M | 1.1M | 5.20 | |
| Endocyte | 3.5 | $5.0M | 466k | 10.68 | |
| Sophiris Bio | 1.3 | $1.9M | 500k | 3.70 | |
| Dendreon Corporation | 0.2 | $238k | 80k | 2.99 | |
| Opko Health (OPK) | 0.1 | $94k | 11k | 8.40 | |
| Ambit Bioscience | 0.0 | $0 | 46.00 | 0.00 |
